Target intelligence / Profile preview

Novel transcript, antisense to COL4A1

Molecular classification: Long non-coding RNA (lncRNA)

Overview

Novel transcript, antisense to COL4A1 (ENSG00000295764), is a long non-coding RNA gene identified in the human genome. The transcript is transcribed from the strand opposite to COL4A1, a gene encoding collagen type IV alpha-1 chain. There is currently no published evidence of protein-coding capacity, recognized molecular function, direct involvement in disease, or utility as a therapeutic target. Its main feature is being a lncRNA that may regulate or interact with the COL4A1 locus or neighboring genes, but further research is necessary to define any regulatory or biological role[1][3].

Other names: LOC126861856

Beyond the preview

Go deeper on Novel transcript, antisense to COL4A1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to COL4A1.

Explore the full profile